Caitlin C Murphy1, Yang Claire Yang2. 1. Division of Epidemiology, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX. 2. Department of Sociology, Lineberger Cancer Center, and Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Abstract
PURPOSE OF REVIEW: Age-period-cohort (APC) models simultaneously estimate the effects of age - biological process of aging; time period - secular trends that occur in all ages simultaneously; and birth cohort - variation among those born around the same year or from one generation to the next. APC models inform understanding of cancer etiology, natural history, and disparities. We reviewed findings from recent studies (published 2008-2018) examining age, period, and cohort effects and summarized trends in age-standardized rates and age-specific rates by birth cohort. We also described prevalence of cancer risk factors by time period and birth cohort, including obesity, current smoking, human papilloma virus (HPV), and hepatitis C virus (HCV). RECENT FINDINGS: Studies (n=29) used a variety of descriptive analyses and statistical models to document age, period, and cohort trends in cancer-related outcomes. Cohort effects predominated, particularly in breast, bladder, and colorectal cancers, whereas period effects were more variable. No effect of time period was observed in studies of breast, bladder, and oral cavity cancers. Age-specific prevalence of obesity, current smoking, HPV, and HCV also varied by birth cohort, which generally paralleled cancer incidence and mortality rates. SUMMARY: We observed strong cohort effects across multiple cancer types and less consistent evidence supporting the effect of time period. Birth cohort effects point to exposures early in life - or accumulated across the life course - that increase risk of cancer. Birth cohort effects also illustrate the importance of reconsidering the timing and duration of well-established risk factors to identify periods of exposure conferring the greatest risk.
PURPOSE OF REVIEW: Age-period-cohort (APC) models simultaneously estimate the effects of age - biological process of aging; time period - secular trends that occur in all ages simultaneously; and birth cohort - variation among those born around the same year or from one generation to the next. APC models inform understanding of cancer etiology, natural history, and disparities. We reviewed findings from recent studies (published 2008-2018) examining age, period, and cohort effects and summarized trends in age-standardized rates and age-specific rates by birth cohort. We also described prevalence of cancer risk factors by time period and birth cohort, including obesity, current smoking, human papilloma virus (HPV), and hepatitis C virus (HCV). RECENT FINDINGS: Studies (n=29) used a variety of descriptive analyses and statistical models to document age, period, and cohort trends in cancer-related outcomes. Cohort effects predominated, particularly in breast, bladder, and colorectal cancers, whereas period effects were more variable. No effect of time period was observed in studies of breast, bladder, and oral cavity cancers. Age-specific prevalence of obesity, current smoking, HPV, and HCV also varied by birth cohort, which generally paralleled cancer incidence and mortality rates. SUMMARY: We observed strong cohort effects across multiple cancer types and less consistent evidence supporting the effect of time period. Birth cohort effects point to exposures early in life - or accumulated across the life course - that increase risk of cancer. Birth cohort effects also illustrate the importance of reconsidering the timing and duration of well-established risk factors to identify periods of exposure conferring the greatest risk.
Entities:
Keywords:
Incidence; SEER program; age factors; risk factors; time factors
Authors: P Brennan; O Bogillot; S Cordier; E Greiser; W Schill; P Vineis; G Lopez-Abente; A Tzonou; J Chang-Claude; U Bolm-Audorff; K H Jöckel; F Donato; C Serra; J Wahrendorf; M Hours; A T'Mannetje; M Kogevinas; P Boffetta Journal: Int J Cancer Date: 2000-04-15 Impact factor: 7.396
Authors: P Brennan; O Bogillot; E Greiser; J Chang-Claude; J Wahrendorf; S Cordier; K H Jöckel; G Lopez-Abente; A Tzonou; P Vineis; F Donato; M Hours; C Serra; U Bolm-Audorff; W Schill; M Kogevinas; P Boffetta Journal: Cancer Causes Control Date: 2001-06 Impact factor: 2.506
Authors: Rebecca Smith-Bindman; Philip W Chu; Diana L Miglioretti; Edward A Sickles; Roger Blanks; Rachel Ballard-Barbash; Janet K Bobo; Nancy C Lee; Matthew G Wallis; Julietta Patnick; Karla Kerlikowske Journal: JAMA Date: 2003-10-22 Impact factor: 56.272
Authors: Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West Journal: BMC Med Res Methodol Date: 2022-05-19 Impact factor: 4.612
Authors: Femmie de Vegt; Jessie J J Gommers; Hans Groenewoud; Peter D Siersema; André L M Verbeek; Yonne Peters; Mireille J M Broeders Journal: Int J Cancer Date: 2021-10-16 Impact factor: 7.316